Saving on Multi-Source Drugs in Ohio’s Medicaid Program

In my testimony today, I offer evidence that there exists a good opportunity to achieve savings in Ohio’s Medicaid drug program without cutting benefits or quality of care. I will begin my testimony with a brief comment about the Medicaid program in Ohio, then discuss research I have recently published on overspending on certain drugs in Medicaid both nationally and in Ohio, and conclude with a remark regarding possible policy options to consider.